SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-18-010920
Filing Date
2018-10-09
Accepted
2018-10-09 16:16:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT gtbp_424b3.htm 424B3 581822
2 IMAGE gtbp_424b3000.jpg GRAPHIC 4167
3 IMAGE gtbp_424b3001.jpg GRAPHIC 5413
  Complete submission text file 0001654954-18-010920.txt   596590
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-223349 | Film No.: 181113840
SIC: 2834 Pharmaceutical Preparations